Stock 688016 SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shanghai MicroPort Endovascular MedTech Co., Ltd.

Equities

688016

CNE100003MJ5

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
174.9 CNY -3.12% Intraday chart for Shanghai MicroPort Endovascular MedTech Co., Ltd. +2.64% -10.15%
Apr. 26 Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 23 Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 10,578 18,081 17,904 13,607 16,101 14,467 - -
Enterprise Value (EV) 1 10,578 17,030 16,669 12,639 13,145 11,769 11,450 10,574
P/E ratio 63.6 x 84.3 x 56.7 x 38.1 x 28.6 x 22.6 x 17.7 x 13.5 x
Yield 0.44% 0.36% 0.84% 1.22% 1.54% 2.18% 2.34% 3.57%
Capitalization / Revenue 31.7 x 38.4 x 26.2 x 15.2 x 13.6 x 9.42 x 7.38 x 5.69 x
EV / Revenue 31.7 x 36.2 x 24.3 x 14.1 x 11.1 x 7.66 x 5.84 x 4.16 x
EV / EBITDA 62.3 x 64.1 x 43.7 x 28.2 x 21.6 x 15.6 x 12.1 x 8.13 x
EV / FCF - - - 318 x 35.7 x 27.3 x 26.1 x 19.6 x
FCF Yield - - - 0.31% 2.8% 3.66% 3.83% 5.11%
Price to Book 9.92 x 14.7 x 12 x 7.92 x 4.19 x 3.59 x 3.2 x 2.68 x
Nbr of stocks (in thousands) 71,978 71,978 71,978 71,978 82,726 82,726 - -
Reference price 2 147.0 251.2 248.7 189.0 194.6 174.9 174.9 174.9
Announcement Date 2/28/20 2/26/21 2/24/22 2/27/23 2/23/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 333.7 470.3 684.6 896.5 1,187 1,536 1,959 2,542
EBITDA 1 169.9 265.5 381.1 448.7 608.8 754.3 949.3 1,301
EBIT 1 164.3 249.9 362.8 415.2 573.9 744.7 948.3 1,236
Operating Margin 49.22% 53.15% 52.99% 46.31% 48.34% 48.48% 48.4% 48.63%
Earnings before Tax (EBT) 1 164.3 249.6 361.7 413.9 572.3 753.8 952.4 1,244
Net income 1 141.8 214.6 315.9 356.9 492.4 629.9 798.4 1,067
Net margin 42.48% 45.64% 46.14% 39.81% 41.48% 41% 40.75% 41.99%
EPS 2 2.310 2.980 4.390 4.960 6.810 7.736 9.876 12.94
Free Cash Flow 1 - - - 39.78 368 431 439 540
FCF margin - - - 4.44% 31% 28.06% 22.4% 21.24%
FCF Conversion (EBITDA) - - - 8.87% 60.45% 57.14% 46.24% 41.52%
FCF Conversion (Net income) - - - 11.15% 74.74% 68.43% 54.99% 50.59%
Dividend per Share 2 0.6500 0.9000 2.100 2.300 3.000 3.812 4.100 6.240
Announcement Date 2/28/20 2/26/21 2/24/22 2/27/23 2/23/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 174.5 257.9 200.9 205.4 232.3 285.6 336 266.8 298.7 358.1 382.6 382.6 442.1 - -
EBITDA - - - - - - - - - - - - - - -
EBIT 1 70.51 141.4 109.1 98.7 66.02 144.5 182.4 126 120.6 217.8 175.3 175.3 202.6 - -
Operating Margin 40.41% 54.84% 54.29% 48.04% 28.43% 50.61% 54.29% 47.21% 40.38% 60.81% 45.81% 45.81% 45.81% - -
Earnings before Tax (EBT) 1 70.37 141.2 109.1 98.27 65.3 144.9 181.3 126 120.5 216.8 178.7 178.7 241.2 - -
Net income 1 65.87 123.5 91.55 85.85 56 124.8 155.1 108.9 104 184.3 152.8 154 209.1 - -
Net margin 37.75% 47.88% 45.57% 41.79% 24.11% 43.71% 46.15% 40.81% 34.81% 51.47% 39.95% 40.25% 47.3% - -
EPS 2 0.9200 1.720 1.270 1.190 0.7800 1.730 2.160 1.520 1.410 2.230 1.848 1.862 2.528 - -
Dividend per Share 2 2.100 - - - 2.300 - - - 3.000 - - - 3.936 - -
Announcement Date 2/24/22 4/29/22 8/25/22 10/28/22 2/27/23 4/27/23 7/28/23 10/27/23 2/23/24 4/26/24 - - - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 - 1,051 1,234 968 2,956 2,699 3,017 3,893
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - - 39.8 368 431 439 540
ROE (net income / shareholders' equity) 24.7% 18.7% 23.2% 22.2% 26.4% 16.4% 18.5% 19.2%
ROA (Net income/ Total Assets) 19.9% 17% 20.2% - 15.8% 14.6% 16.6% 17.5%
Assets 1 712.3 1,266 1,566 - 3,119 4,326 4,815 6,117
Book Value Per Share 2 14.80 17.10 20.80 23.90 46.50 48.70 54.70 65.30
Cash Flow per Share 2 2.330 3.020 4.170 4.640 6.750 7.510 9.540 11.80
Capex 1 21.2 26.2 89.6 294 190 235 215 213
Capex / Sales 6.36% 5.58% 13.08% 32.79% 16.03% 15.3% 10.98% 8.39%
Announcement Date 2/28/20 2/26/21 2/24/22 2/27/23 2/23/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Shanghai MicroPort Endovascular MedTech Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
174.9 CNY
Average target price
237.4 CNY
Spread / Average Target
+35.74%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-10.15% 2B
STRYKER CORPORATION Stock Stryker Corporation
+12.07% 128B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-9.04% 10.65B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+0.91% 8.82B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
+16.72% 7.19B
GLAUKOS CORPORATION Stock Glaukos Corporation
+25.15% 4.99B
AXONICS, INC. Stock Axonics, Inc.
+7.17% 3.4B
ENOVIS CORPORATION Stock Enovis Corporation
-1.36% 3.03B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-8.73% 2.14B
DOUBLE MEDICAL TECHNOLOGY INC. Stock Double Medical Technology Inc.
-22.81% 1.79B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. 688016 Stock
  4. Financials Shanghai MicroPort Endovascular MedTech Co., Ltd.